FDA Approves New HIV Drug for Adults with Limited Treatment Options
U.S. Food and Drug Administration
The new medication is for those whose HIV infections cannot be successfully treated with other treatments
HIV diagnosis
Encouraging Findings in First-in-Human Clinical Trial Evaluating HIV Vaccine
The Scripps Research Institute
Scripps Research publish study data in Science, helping validate novel vaccination strategy
COVID-19 Disruptions in HIV Testing, Prevention Highlight Need for Innovation
Centers for Disease Control and Prevention
The rapid rebound in services, if scaled up, could help reach national prevention goals
A Better Understanding of How HIV-1 Evades the Immune System
University of Montreal
The expression of Vpu helps infected cells evade the ADCC elimination method
Testing for Monkeypox Virus Coinfections
Pallavi Upadhyay, PhD
Everything you need to know about monkeypox and its potential coinfections
Early HIV Diagnosis and Treatment Important for Better Health Outcomes
National Institutes of Health
Findings based on an extended follow-up of participants in the START study
Four Decades of HIV Testing: Where Do We Stand?
Pallavi Upadhyay, PhD
Rapid point-of-care tests and self-tests are critical tools toward eradicating HIV
International Reproducibility Efforts in Clinical Flow Cytometry
Zahraa Chorghay, PhD
How can we achieve interlaboratory standardization of flow cytometry assays?
Humans versus Pathogens: COVID-19 and Beyond
Zahraa Chorghay, PhD
Advances in COVID-19 detection can also give us a fighting chance against other pathogens
Implementing Rapid HIV Testing for the Emergency Department
Adam J. McShane, PhD, DABCC (CC, TC), FAACC
Making rapid HIV testing available in emergency departments supports early detection to reduce transmission